You are not authorized to access this page.
Search Within

Larry Norton

Formats
  1. Journal Article (411)
  2. Meeting Abstract (297)
  3. Book Section (21)
  4. Conference Paper (16)
  5. Editorial (8)
  6. Guidelines (3)
  7. Correspondence (2)
  8. Miscellaneous (2)
  9. Book Whole (1)
  10. Review (1)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (762)
  2. Breast Medicine Service (762)
  3. Department of Medicine (762)
  4. Solid Tumor Oncology Division (762)
  5. Survivorship Research (393)
  6. GSK Faculty (224)

More Groups

People
  1. Clifford Hudis (293)
  2. Edi Brogi (115)
  3. Andrew Seidman (99)
  4. Sujata Patil (97)
  5. Mark Robson (90)
  6. Hannah Wen (83)

More People

Years
  1. 2025 (9)
  2. 2024 (19)
  3. 2023 (18)
  4. 2022 (16)
  5. 2021 (13)
  6. 2020 (26)

More Years

Publications
  1. Journal of Clinical Oncology (156)
  2. Cancer Research (79)
  3. Breast Cancer Research and Treatment (48)
  4. Clinical Cancer Research (31)
  5. Laboratory Investigation (26)
  6. Modern Pathology (24)

More Publications

Publishers
  1. American Society of Clinical Oncology (160)
  2. American Association for Cancer Research (125)
  3. Nature Publishing Group (77)
  4. Springer (61)
  5. Oxford University Press (50)
  6. Elsevier Inc. (43)

More Publishers

Results (762)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of the 2018 ASCO/CAP HER2 guideline updates on HER2 assessment in breast cancer with HER2 immunohistochemistry equivocal results
    Meeting Abstract

    Wen, H.; Ventura, K.; Xu, J.; Ross, D.; Dang, C.; Robson, M.; Norton, L.; Morrow, M.; Brogi, E.
    Laboratory Investigation (2019)

    Fulltext@MSK | Save
  • Are metaplastic breast carcinomas and uterine carcinosarcomas genetically related?
    Meeting Abstract

    Da Cruz Paula, A.; Brown, D.; Geyer, F.; Smith, E.; Pareja, F.; Papanastasiou, A.; Fusco, N.; Marchio, C.; Brogi, E.; Wen, H.; more...
    Laboratory Investigation (2019)

    Fulltext@MSK | Save
  • Phase Ib/II study of capecitabine 7/7 schedule with neratinib in patients with HER2-positive metastatic breast cancer (MBC)
    Meeting Abstract

    Wang, R.; Singh, J.; Sterlin, V.; Goldstein, M.; Lake, D.; Wong, S.; Baselga, J.; Norton, L.; Dang, C.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Metaplastic breast carcinomas and uterine carcinosarcomas are histologically and genetically related
    Meeting Abstract

    Da Cruz Paula, A.; Brown, D.; Geyer, F. C.; Smith, E.; Pareja, F.; Papanastasiou, A. D.; Fusco, N.; Marchio, C.; Brogi, E.; Wen, H. Y.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • A randomized phase II study of peri-operative ipilimumab, nivolumab and cryoablation versus standard peri-operative care in women with residual triple negative early stage/resectable breast cancer after standard-of-care neoadjuvant chemotherapy
    Meeting Abstract

    McArthur, H. L.; Comen, E. A.; Solomon, S.; Rodine, M.; DiLauro Abaya, C.; Leal, J. H. S.; Patil, S.; Norton, L.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Whole exome sequencing analysis of the progression from ductal carcinoma in situ to invasive ductal carcinoma
    Meeting Abstract

    Lee, J. Y.; Bi, R.; Pareja, F.; Geyer, F. C.; Brown, D.; Wen, H. Y.; Norton, L.; Hicks, J.; Weigelt, B.; Reis-Filho, J. S.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Tumor epichaperome expression using (124)I PU-H71 PET (PU-PET) as a biomarker of response for PU-H71 plus nab-paclitaxel in HER2 negative (HER2-) metastatic breast cancer (MBC)
    Meeting Abstract

    Jhaveri, K.; Dunphy, M.; Wang, R.; Comen, E.; Fornier, M.; Moynahan, M. E.; Bromberg, J.; Ma, W.; Patil, S.; Taldone, T.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Homologous recombination DNA repair defects in PALB2-associated breast cancers
    Journal Article

    Li, A.; Geyer, F. C.; Blecua, P.; Lee, J. Y.; Selenica, P.; Brown, D. N.; Pareja, F.; Lee, S. S. K.; Kumar, R.; Rivera, B.; more...
    npj Breast Cancer (2019)

    Fulltext@MSK | Save
  • Phase II study of weekly paclitaxel with trastuzumab and pertuzumab in patients with human epidermal growth receptor 2 overexpressing metastatic breast cancer: 5-year follow-up
    Journal Article

    Wang, R.; Smyth, L. M.; Iyengar, N.; Chandarlapaty, S.; Modi, S.; Jochelson, M.; Patil, S.; Norton, L.; Hudis, C. A.; Dang, C. T.
    The Oncologist (2019)

    Fulltext@MSK | Save
  • Association between bone mineral density and incidence of breast cancer: A population based study
    Meeting Abstract

    Fraenkel, M.; Mizrakli, Y.; Koretz, M.; Norton, L.; Shafat, T.; Medvedovsky, V.; Geffen, D. B.; Novack, V.; Siris, E.
    Osteoporosis International (2019)

    Fulltext@MSK | Save